Trials / Recruiting
RecruitingNCT04690660
Swiss Postpartum Hypertension Cohort
Swiss Postpartum Hypertension Cohort (Swiss-PPHT)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 480 (estimated)
- Sponsor
- University Hospital, Basel, Switzerland · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This open label, prospective observational, single-center registry is to study short-, intermediate-and long-term course of postpartum hypertension and predictors/risk factors associated with long term cardiovascular and renal risk. Current disease management strategies will be evaluated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Data collection for parameters of organ damage (cardiac and renal blood markers) | Blood results will be taken out of next routine venipuncture. Routinely collected standard parameters are a blood count, chemistry panel including renal parameters and electrolytes, lipid profile and a HbA1c as well as albumin/creatinine and protein/creatinine ratio in urine. |
| OTHER | Data collection for blood pressure (BP) | Clinic blood pressure and 24hour BP Measurements |
| OTHER | Home-based blood pressure management (substudy) | Subjects participating in home-based blood pressure management via telemonitoring will receive a free HekaHealth application (App) for the structured assessment of HBPM. |
| OTHER | Biomarker Profiles (substudy) | Substudy where possible cardiac, renal and pregnancy related biomarkers will be additionally analyzed. The following biomarkers will be analyzed: N terminal (NT)-proBNP, Troponin, elevated mid-regional pro-atrial natriuretic peptide (ANP), elevated mid-regional pro adrenomedullin (ADM), soluble fms-like tyrosine kinase (sFlt-1), and placenta growth factor (PlGF). |
| OTHER | Data collection on patient reported outcomes | Data collection on patient reported outcomes (Questionnaire EQ-5D, Questionnaire for App based monitoring ) |
Timeline
- Start date
- 2020-06-04
- Primary completion
- 2030-05-01
- Completion
- 2030-05-01
- First posted
- 2020-12-31
- Last updated
- 2025-05-28
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT04690660. Inclusion in this directory is not an endorsement.